GlassScriptPhysician profile
David G Rizik
NPI 1700862984
$128,003.67
in general payments reported to CMS, 2019-2025
31 companies · $8,892 in 2025
The $8,892 reported for 2025 was more than what 94% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $45K · 2020: $26K · 2021: $2,408 · 2022: $14K · 2023: $22K · 2024: $10K · 2025: $8,892.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $17K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $14K · Food and Beverage: $6,615 · Consulting Fee: $3,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $16,764.36 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $14,400.00 |
| Food and Beverage | $6,614.86 |
| Consulting Fee | $3,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $69,812.15 | 2019-2025 | General - Therapies, Watchman Access System, Watchman Flx |
| Siemens Medical Solutions USA, INC. | $22,328.91 | 2019-2025 | Acuson Origin Diagnostic Ultrasound System, Artis Icono Floor, Acuson Sc2000 Diagnostic Ultrasound System |
| Abbott Laboratories | $14,603.35 | 2019-2025 | Mitraclip, Pressurewire, Portico |
| Medtronic, INC. | $13,835.96 | 2021-2025 | Corevalve Evolut R, Apollotm, Cardioblate |
| Edwards Lifesciences Corporation | $2,502.50 | 2023-2025 | Evoque, Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Teleflex LLC | $838.62 | 2025 | Manta, Orsiro Mission, Guideliner |
| Medtronic Vascular, INC. | $564.22 | 2019-2020 | |
| Philips North America LLC | $550.97 | 2021-2023 | |
| Shockwave Medical, INC | $387.80 | 2021-2025 | |
| Livanova USA, INC. | $355.60 | 2019 | |
| Biotronik INC. | $335.69 | 2019 | |
| Heartflow, INC. | $331.55 | 2020-2025 | Ffrct |
| Acist Medical Systems, INC. | $311.01 | 2021-2024 | |
| Abiomed | $310.49 | 2019-2022 | |
| Neovasc Medical INC | $163.98 | 2021 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $140.84 | 2019-2024 | |
| Astrazeneca Pharmaceuticals LP | $126.64 | 2019-2021 | |
| Asahi Intecc USA, INC. | $118.75 | 2023 | Asahi Ptca Guide Wire |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $74.12 | 2020-2024 | Lifevest |
| Bardy Diagnostics, INC. | $50.00 | 2019-2020 | |
| Mimedx Group, INC. | $46.30 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $45.21 | 2019-2021 | |
| Pfizer INC. | $41.64 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $28.46 | 2020 | |
| Genzyme Corporation | $28.33 | 2019 | |
| Kestra Medical Technology Services, INC. | $19.78 | 2023 | Assure Wcd |
| Sanofi-Aventis U.S. LLC | $18.85 | 2020 | |
| Amgen INC. | $16.65 | 2021 | |
| Chiesi USA, INC. | $15.30 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Rizik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.